HEALTHIT.COM
Research
RESEARCH PREVIEW · 2026-08-27
Menu
2026-08-22Corti achieves ISO/IEC 270012026-08-22Geisinger case: 70% faster prior auth TAT2026-08-22Infinitus SOC 2 Type II compliance2026-08-22AKASA HITRUST/SOC 2 and 100% pre-bill review2026-08-22Infinitus 2025 recap: 1.17M patients automated2026-08-22HIPAA/SOC 2 Type II; recordings deleted2026-08-19Luma-PCC partnership to bring AI-enabled communications to 300+ pediatric practices2026-08-15Glass ranks top-tier on ARISE NOHARM clinical safety benchmark2026-08-15ISO 27001, HIPAA, 7+ FDA 510(k)s documented2026-08-15UpToDate integrated into Epic EHR/MyChart and ambient AI workflows2026-08-06UpToDate Expert AI adopted by ~2,500 U.S. hospitals and health systems2026-07-292.7M weekly interactions; US CAB launch2026-07-23Anterior-Stellarus partnership2026-07-23Strategic partnership with Stellarus to enable real-time AI-driven prior authorization for health plans2026-07-22Waystar Q2 2026 beat; AI anomaly detection traction2026-07-21Patient Pipeline: AI-powered new patient acquisition from ad spend to booked care2026-07-21Luma launches AI Patient Pipeline for new patient acquisition2026-07-07SMART on FHIR + Epic Toolbox integration2026-06-30Nature Health SAFEMOM study shows Ada improves health-seeking behavior on MomConnect2026-06-26Modality Partnership (NHS) rolls out Heidi across 53 sites in the UK's largest clinical deployment of ambient AI2026-06-26NHS Modality Partnership rollout2026-06-24Roche acquires PathAI for ~$1B to bolster AI-based diagnostic algorithms2026-06-24Assort Health raises $120M Series C at $1.2B valuation2026-06-15Thoreau Group signs $12B agreement to take control of Ensemble Health

Workflow · Imaging & Diagnostic AI

Evidence readiness landscape

Documentary evidence, scenario match, and comparability are separate judgments.

0 of 7 products currently pass the documentary gate. 0 are scenario-comparable. Ranking stays closed until at least two products are comparable in the same scenario.

No ranking available yet — here is what would change that

  • Aidoc aiOS needs: deployment traction, economic value, evidence strength, independent source present, interoperability and fresher evidence (currently historical). View its record →
  • Cleerly Coronary Analysis needs: deployment traction, economic value, evidence strength, independent source present, interoperability and fresher evidence (currently historical). View its record →
  • HeartFlow Analysis (FFRct) needs: deployment traction, economic value, independent source present, interoperability and fresher evidence (currently historical). View its record →
ProductDecision statusEvidence readinessCritical unknownLast verified
Aidoc aiOS○ Historical · Research only246d median · 0/3 confirmedscaled production deployment
Cleerly Coronary Analysis○ Historical · Research only528d median · 0/2 confirmedscaled production deployment
HeartFlow Analysis (FFRct)○ Historical · Research only897d median · 2/4 confirmedscaled production deployment2026-08-27
Lunit INSIGHT○ Historical · Research only1262d median · 0/2 confirmedscaled production deployment
qXR (Chest X-ray AI Suite)○ Historical · Research only150d median · 0/6 confirmedscaled production deployment
Rapid CTA○ Historical · Research only1341d median · 0/2 confirmedscaled production deployment
Viz.ai One Platform○ Historical · Research only913d median · 1/3 confirmeddocumented economic outcomes2026-08-27

The documentary gate requires Current/Aging freshness AND gate-confirmed coverage on all four decision-critical dimensions including an independent source class. Products failing any condition render research-only with their exact gaps. Composite scores appear only inside each product’s assurance record as a diagnostic — never here. Documentary pass is not scenario eligibility, comparability, or decision readiness.